Ran Wei
Impact in
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
- Cancer Research top 5%
- Breast Cancer Treatment Studies
Papers in
-
- Advanced Breast Cancer Therapies 18
- Gastric Cancer Management and Outcomes 4
- Oncology 21
- Lung Cancer Research Studies 6
- HER2/EGFR in Cancer Research 6
- Co-authors
- Hang Fai Kwok (8 shared papers)Libin Guo (2 shared papers)Yao Lin (3 shared papers)Siew Eng Chua (3 shared papers)Grainne Mary McAlonan (3 shared papers)Qi Li (3 shared papers)Chris Shaw (3 shared papers)Edward Sai Kam Hui (2 shared papers)
- Journals
- Annals of Oncology (11 papers)Scientific Reports (4 papers)The Oncologist (3 papers)Frontiers in Immunology (2 papers)Frontiers in Plant Science (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ran Wei
100 papers receiving 2.7k citations
Ran Wei's Hit Papers
Peers
Comparison fields: 5 of 127
- Biological Psychiatry 115
- Cancer Research 570
- Pulmonary and Respiratory Medicine 755
- Oncology 615
- Behavioral Neuroscience 59
Countries citing papers authored by Ran Wei
This map shows the geographic impact of Ran Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Wei more than expected).
Fields of papers citing papers by Ran Wei
This network shows the impact of papers produced by Ran Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Wei. The network helps show where Ran Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Ran Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 104 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial Hit paper breakdown → | 2022 | 400 |
| 2 | Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study Hit paper breakdown → | 2021 | 273 |
| 3 | Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes Hit paper breakdown → | 2024 | 147 |
| 4 | 2009 | 131 | |
| 5 | 2017 | 126 | |
| 6 | 2013 | 122 | |
| 7 | 2013 | 85 | |
| 8 | 2013 | 85 | |
| 9 | 2020 | 71 | |
| 10 | 2020 | 61 | |
| 11 | 2019 | 56 | |
| 12 | 2010 | 53 | |
| 13 | 2017 | 51 | |
| 14 | 2021 | 39 | |
| 15 | 2019 | 38 | |
| 16 | 2018 | 38 | |
| 17 | 2022 | 36 | |
| 18 | 2021 | 32 | |
| 19 | 2015 | 31 | |
| 20 | 2020 | 29 |
About Ran Wei
Ran Wei is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 104 papers that have together received 2.7k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (18 papers), Lung Cancer Research Studies (6 papers), HER2/EGFR in Cancer Research (6 papers), Epigenetics and DNA Methylation (5 papers), Insect-Plant Interactions and Control (4 papers), Cancer-related gene regulation (4 papers), Bone and Dental Protein Studies (4 papers) and Gastric Cancer Management and Outcomes (4 papers). The work is most often cited by research in Biological Psychiatry (115 citations), Cancer Research (570 citations), Pulmonary and Respiratory Medicine (755 citations), Oncology (615 citations) and Behavioral Neuroscience (59 citations). Ran Wei has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Hang Fai Kwok, Libin Guo, Yao Lin, Siew Eng Chua, Grainne Mary McAlonan, Qi Li, Chris Shaw, Edward Sai Kam Hui, Charlton Cheung and EX Wu. Their work appears in journals such as Annals of Oncology, Scientific Reports, The Oncologist, Frontiers in Immunology and Frontiers in Plant Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.